CereGate
Company · Munich, Germany
Builds software that lets implanted neurostimulators "write" information back into the nervous system, e.g. to improve gait in Parkinson's disease.
In the news
FundingNeuromodulation
CereGate closes oversubscribed Series C led by an unnamed US medtech company
Munich-based CereGate, which builds brain-computer interface software that runs on deep brain stimulation systems, closed a Series C round to fund clinical work on freezing of gait in Parkinson's disease. The amount was not disclosed.